Tygh Capital Management, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$3,848,000
+4.1%
35,924
-0.0%
0.49%
-1.6%
Q3 2021$3,695,000
+26.2%
35,940
+8.0%
0.50%
+25.3%
Q2 2021$2,927,000
-10.5%
33,274
-1.0%
0.40%
-13.6%
Q1 2021$3,269,000
-9.8%
33,622
+4.1%
0.46%
-18.1%
Q4 2020$3,623,000
+20.9%
32,303
-0.1%
0.56%
-0.7%
Q3 2020$2,996,00032,3220.57%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders